DE602008005228D1 - Die Proteinserum-Amyloid P-Komponente (SAP, SAMP) als Prognose- und Diagnose-Marker für die pränatale Diagnose von Trisomie 21 (Down Syndrom) - Google Patents

Die Proteinserum-Amyloid P-Komponente (SAP, SAMP) als Prognose- und Diagnose-Marker für die pränatale Diagnose von Trisomie 21 (Down Syndrom)

Info

Publication number
DE602008005228D1
DE602008005228D1 DE602008005228T DE602008005228T DE602008005228D1 DE 602008005228 D1 DE602008005228 D1 DE 602008005228D1 DE 602008005228 T DE602008005228 T DE 602008005228T DE 602008005228 T DE602008005228 T DE 602008005228T DE 602008005228 D1 DE602008005228 D1 DE 602008005228D1
Authority
DE
Germany
Prior art keywords
trisomy
down syndrome
samp
sap
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602008005228T
Other languages
English (en)
Inventor
George Tsangaris
Konstantinos Vougas
Aggeliki Kolialexi
Ariadni Mavrou-Kalpini
Aristidis Antsaklis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FOUNDATION OF BIOMEDICAL RES OF ACADEMY OF ATHENS
Original Assignee
FOUNDATION OF BIOMEDICAL RES OF ACADEMY OF ATHENS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FOUNDATION OF BIOMEDICAL RES OF ACADEMY OF ATHENS filed Critical FOUNDATION OF BIOMEDICAL RES OF ACADEMY OF ATHENS
Publication of DE602008005228D1 publication Critical patent/DE602008005228D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DE602008005228T 2007-10-26 2008-10-13 Die Proteinserum-Amyloid P-Komponente (SAP, SAMP) als Prognose- und Diagnose-Marker für die pränatale Diagnose von Trisomie 21 (Down Syndrom) Active DE602008005228D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20070100651A GR1006121B (el) 2007-10-26 2007-10-26 Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down)

Publications (1)

Publication Number Publication Date
DE602008005228D1 true DE602008005228D1 (de) 2011-04-14

Family

ID=40030173

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602008005228T Active DE602008005228D1 (de) 2007-10-26 2008-10-13 Die Proteinserum-Amyloid P-Komponente (SAP, SAMP) als Prognose- und Diagnose-Marker für die pränatale Diagnose von Trisomie 21 (Down Syndrom)

Country Status (11)

Country Link
EP (1) EP2053407B1 (de)
AT (1) ATE500513T1 (de)
CY (1) CY1112415T1 (de)
DE (1) DE602008005228D1 (de)
DK (1) DK2053407T3 (de)
ES (1) ES2362051T3 (de)
GR (1) GR1006121B (de)
HR (1) HRP20110371T1 (de)
PL (1) PL2053407T3 (de)
PT (1) PT2053407E (de)
SI (1) SI2053407T1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104849471A (zh) * 2015-04-22 2015-08-19 戴勇 唐氏综合征图谱模型的构建方法
CN112924686B (zh) * 2019-12-05 2024-08-23 复旦大学 用于检测血清淀粉样蛋白a的免疫层析试纸条及其制备与检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027216A1 (en) 2001-07-02 2003-02-06 Kiernan Urban A. Analysis of proteins from biological fluids using mass spectrometric immunoassay
WO2005021793A1 (en) 2003-08-29 2005-03-10 Pantarhei Bioscience B.V. Prenatal diagnosis of down syndrome by detection of fetal rna markers in maternal blood
PL1720611T3 (pl) 2004-02-16 2010-09-30 Proteosys Ag Marker diagnostyczny dla raka

Also Published As

Publication number Publication date
PL2053407T3 (pl) 2011-07-29
PT2053407E (pt) 2011-05-10
GR1006121B (el) 2008-10-24
ATE500513T1 (de) 2011-03-15
EP2053407B1 (de) 2011-03-02
SI2053407T1 (sl) 2011-06-30
EP2053407A1 (de) 2009-04-29
DK2053407T3 (da) 2011-06-20
HRP20110371T1 (hr) 2011-06-30
ES2362051T3 (es) 2011-06-27
CY1112415T1 (el) 2015-12-09

Similar Documents

Publication Publication Date Title
MX2007005053A (es) Metodo para evaluar la enfermedad de alzheimer y reactivo de diagnostico.
WO2010053587A3 (en) Methods of monitoring conditions by sequence analysis
TW200643175A (en) Markers for prenatal diagnosis and monitoring
DK0994963T4 (da) Noninvasiv prænatal diagnose
WO2010132447A3 (en) Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
Cacciatore et al. Butyryl-cholinesterase is related to muscle mass and strength. A new biomarker to identify elderly subjects at risk of sarcopenia
Yuksel et al. Is multiple sclerosis a risk factor for atherosclerosis?
CA2645302C (en) Diagnosis and prognosis of dipeptidyl peptidase-associated disease states
EP2081029A3 (de) Biomarker zur Diagnose diabetischer Retinopathie
WO2007106838A3 (en) A non-invasive method for diagnosing fetal cells and cancer cells
DE602006013453D1 (de) Verfahren zur anreicherung fötaler zellen
NZ592819A (en) Thyroid analyte detection and measurement
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
DE602008005228D1 (de) Die Proteinserum-Amyloid P-Komponente (SAP, SAMP) als Prognose- und Diagnose-Marker für die pränatale Diagnose von Trisomie 21 (Down Syndrom)
WO2009133197A3 (en) Levels of april in serum and use in diagnostic methods
WO2006029052A8 (en) Methods for assessing atherosclerosis
Huang et al. P3-182 EXAMINING THE ASSOCIATION BETWEEN CIRCULATING INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) AND BRAIN ACTIVITY IN OLDER ADULTS
WO2016010401A8 (ko) 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법
Duran et al. Relation between serum PAPP-A level and umbilical cord thickness during first trimester of pregnancy
Kim et al. Non-invasive prenatal diagnosis using cell-free nucleic acids in maternal blood
Potenza Adolescent addiction: developmental, biological and clinical considerations
ROSS et al. Testing for Gestational Diabetes Mellitus in Australia
Wong Non-Invasive Prenatal Testing (NIPT) for Down syndrome
UA76269U (uk) Спосіб стратифікації кардіоваскулярного ризику при неалкогольній жировій хворобі печінки
WO2007007185A3 (en) Assay